人类精子蛋白质组学研究
本文概述了精子蛋白质组学研究的关键实验设计步骤、迄今已鉴定超过6000种成熟精子蛋白,并总结了比较研究揭示的与获能及多种不育表型相关的蛋白标志物,同时指出精液样本异质性导致各研究间重叠度较低。
要点
- 精子蛋白质组学已描述超过6000种成熟精子蛋白,涉及精子功能与精浆通讯。
- 比较蛋白谱可识别与获能及弱精、少精等不育表型相关的差异蛋白。
- 精液样本固有异质性和个体间变异导致各蛋白质组学研究间重叠度相对较低。
核心结论
- 蛋白质组学为鉴定和定量精液成分中数千种蛋白提供了强大方法,但需合适的实验设计、样本纯化、技术流程和严格的数据分析标准才能获得可靠结果。
- 精液样本的固有异质性和个体间变异导致各蛋白质组学研究报告之间重叠度相对较低,凸显了数据验证策略和严格分析标准的重要性。
研究设计与样本
- 本文为小型综述,概述了开展可靠精子蛋白质组学研究的关键步骤、迄今获得的最相关结果及未来可能方向。
主要发现
- 通过成熟精子细胞的蛋白质组学分析已描述超过6000种蛋白,增进了对精子功能相关过程、精子与精浆间通讯以及蛋白转录来源的认识。
- 比较精子蛋白谱已识别许多参与获能能力获得的蛋白。
- 在弱精症、少精症以及精液参数正常但辅助生殖技术结局不成功的广泛不育表型中,观察到特定蛋白组的丰度改变,从而识别出潜在有临床用途的蛋白生物标志物。
- 蛋白质组学已被用于评估精液样本处理导致的改变,这些改变可能影响生育治疗。
局限性
- 精液样本的固有异质性和个体间变异导致各蛋白质组学研究报告之间重叠度相对较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proteomic methodologies offer a robust approach to identify and quantify thousands of proteins from semen components in both fertile donors and infertile patients. These strategies provide an unprecedented discovery potential, which many research teams are currently exploiting. However, it is essential to follow a suitable experimental design to generate robust data, including proper purification of samples, appropriate technical procedures to increase identification throughput, and data analysis following quality criteria. More than 6000 proteins have been described so far through proteomic analyses in the mature sperm cell, increasing our knowledge on processes involved in sperm function, intercommunication between spermatozoa and seminal fluid, and the transcriptional origin of the proteins. These data have been complemented with comparative studies to ascertain the potential role of the identified proteins on sperm maturation and functionality, and its impact on infertility. By comparing sperm protein profiles, many proteins involved in the acquisition of fertilizing ability have been identified. Furthermore, altered abundance of specific protein groups has been observed in a wide range of infertile phenotypes, including asthenozoospermia, oligozoospermia, and normozoospermia with unsuccessful assisted reproductive techniques outcomes, leading to the identification of potential clinically useful protein biomarkers. Finally, proteomics has been used to evaluate alterations derived from semen sample processing, which might have an impact on fertility treatments. However, the intrinsic heterogeneity and inter-individual variability of the semen samples have resulted in a relatively low overlap among proteomic reports, highlighting the relevance of combining strategies for data validation and applying strict criteria for proteomic data analysis to obtain reliable results. This mini-review provides an overview of the most critical steps to conduct robust sperm proteomic studies, the most relevant results obtained so far, and potential next steps to increase the impact of sperm proteomic data.
引用
- Castillo J, de la Iglesia A, Leiva M, et al. Proteomics of human spermatozoa. Hum Reprod. 2023. PMID: 37632247. doi:10.1093/humrep/dead170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。